Mitegen, XTalQuest Enter Mutual Distribution Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mitegen today announced a mutual distribution agreement with XTalQuest to promote and sell each other's products.

Under the deal, XTalQuest will promote and sell Mitegen's MicroMount, MicroLoop, MicroMesh, RT Aligner, and other products in China, Taiwan, and Singapore. Mitegen will promote and sell XTalQuest's line of crystallization plates, crystallization stock solutions, and other products in North and South America.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.